Details for Menitorix vaccine and its components.
Registered for primary immunisation in infants aged 6 weeks–12 months.
Hib-MenC — combination Haemophilus influenzae type b and meningococcal serogroup C–tetanus toxoid conjugate vaccine
Lyophilised powder in a monodose vial with a pre-filled diluent syringe.
Each 0.5 mL reconstituted dose contains:
- 5 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 12.5 µg tetanus toxoid (PRP-T)
- 5 µg Neisseria meningitidis serogroup C polysaccharide conjugated to 5 µg tetanus toxoid
- traces of trometamol
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
- polyribosylribitol phosphate
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/menitorix.